Results 281 to 290 of about 149,400 (379)

Exploring stimuli‐responsive luminescence in metal halide perovskites for emerging applications

Responsive Materials, EarlyView.
The sensitivity of metal halide perovskites to external stimuli categorizes them as emerging responsive materials. This review systematically discusses their stimuli‐responsive luminescent properties, elucidates their diverse applications in information‐related domains, and outlines the current challenges and prospects.
Yali Zhou, Ziwen Feng, Sisi Li, Zhao‐Qing Liu, Yibo Chen   +4 more
wiley   +1 more source

Lapatinib-Resistant HER2+ Breast Cancer Cells Are Associated with Dysregulation of MAPK and p70S6K/PDCD4 Pathways and Calcium Management, Influence of Cryptotanshinone. [PDF]

Int J Mol Sci
Hernández-Valencia J, García-Villarreal R, Rodríguez-Jiménez M, Hernández-Avalos AD, Rivero IA, Vique-Sánchez JL, Chimal-Vega B, Pulido-Capiz A, García-González V.   +8 more
europepmc   +1 more source

Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein

, 2009
Mohammad Reza Abedini, Emilie J. Muller, Richard Bergeron, Douglas A. Gray, Benjamin K. Tsang   +4 more
openalex   +1 more source

MicroRNA-451 Is Involved in the Self-renewal, Tumorigenicity, and Chemoresistance of Colorectal Cancer Stem Cells [PDF]

, 2011
Nerea Bitarte, Eva Bandrés, Valentina Boni, Ruth Zárate, José Javier Rodríguez, Marisol Gonzalez-Húarriz, Inés López, J. Šola, Marta M. Alonso, Puri Fortes, Jesús García‐Foncillas   +10 more
openalex   +1 more source

Exosome‐Based Theranostic for Gastrointestinal Cancer: Advances in Biomarker Discovery and Therapeutic Engineering

Small Methods, EarlyView.
This review explores the dual roles of exosomes in gastrointestinal (GI) cancers as diagnostic biomarkers and therapeutic agents. It highlights advancements in exosomal miRNAs, lncRNAs, circRNAs, and proteins for cancer detection and prognosis. The study also examines engineering strategies for exosome‐based drug delivery systems, their potential to ...
Mohit J. Mehta, Dongjun Shin, Hyun Sung Park, Jun Su An, Seong Il Lim, Hyun Jin Kim, Seungpyo Hong, Jiyoon Bu   +7 more
wiley   +1 more source

Corrigendum to "DNA-methylation eraser TET2 activates WTIP expression to suppress an AKT-dependent chemoresistance of gastric cancer" [Neoplasia volume 2025 Apr 24:65:101166]. [PDF]

Neoplasia
Guo Y, Yu H, Li J, Liu K, Han M, Tang Y, Su L, Li X, Wu H, Chen D.   +9 more
europepmc   +1 more source

Chemoresistance in non-small-cell lung cancer: can multidrug resistance markers predict the response of xenograft lung cancer models to chemotherapy? [PDF]

, 2011
Johannes Merk, Jana Rolff, Cornelia Dorn, Gunda Leschber, Iduna Fichtner   +4 more
openalex   +1 more source

Nanomedicine for Oral Delivery: Strategies to Overcome the Biological Barriers

Small Methods, EarlyView.
Oral delivery is a preferred administration route for many clinical applications, valued for its strong patient compliance. In this review, how nanoparticles are engineered and deployed to overcome the gastrointestinal barriers that impede clinical translation of oral delivery formulations is examined.
Luke J. Kubiatowicz, Nima Pourafzal, Audrey T. Zhu, Zhongyuan Guo, Ronnie H. Fang, Liangfang Zhang   +5 more
wiley   +1 more source

EZH2 promotes chemoresistance in colorectal cancer by inhibiting autophagy through NRP1 suppression. [PDF]

Biochem J
Deng H, Xu Q, Zhang Q, Liu C, Ren L.
europepmc   +1 more source

Nanozymes in Reactive Oxygen Species‐Dependent Diseases: From Design and Preclinical Studies to Clinical Translation Prospects

Small Structures, EarlyView.
Nanozymes emerge as promising therapeutic agents for reactive oxygen species (ROS)‐dependent diseases, offering advantages over traditional biocatalysts through enhanced stability, tunability, and targeting capabilities. This review explores their mechanisms, design strategies, and clinical progress, emphasizing precision medicine potential.
Lihong Zhou, Jingyu Yan, Chenying Cui, Yurong Xu, Kaifang Zhang, Meijun Du, Zhuowei Zhang, Xiuping Wu, Bing Li   +8 more
wiley   +1 more source